Focused Ultrasound Enhances Brain Delivery of Sorafenib Nanoparticles

Focused Ultrasound Enhances Brain Delivery of Sorafenib Nanoparticles

Glioblastoma (GBM) is a universally lethal form of brain cancer. The success of novel treatments is hindered by the blood–brain barrier (BBB), which prevents most drugs from penetrating GBM tumors. Sorafenib (SFB), a proapoptotic multikinase inhibitor, has been investigated for the treatment of GBM;...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Daniel Dahis, Dana Meron Azagury, Fadi Obeid, Michelle Z. Dion, Alexander M. Cryer, Mariana Alonso Riquelme, Pere Dosta, Ariel William Abraham, Moshe Gavish, Natalie Artzi, Yosi Shamay, Haim Azhari
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Wiley-VCH 2023-02-01
Seri Bilgileri:Advanced NanoBiomed Research
Konular:
blood–brain barrier (BBB)
focused ultrasound
glioblastoma
nanoparticles
sorafenib
Online Erişim:https://doi.org/10.1002/anbr.202200142

Internet

https://doi.org/10.1002/anbr.202200142

Benzer Materyaller